RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

por Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Avilés-Salas, Alejandro, Catalán, Rodrigo, Lara-Mejía, Luis, Samtani-Bassarmal, Suraj, Cardona, Andres F., Mendoza-Desión, Jorge, Hernández-Cueto, Daniel, Maldonado, Altagracia, Baay-Guzmán, Guillermina, Huerta-Yepes, Sara, Arrieta, Oscar
Publicado 2021